Author:
Mercaldo Francesco,Belfiore Maria Paola,Reginelli Alfonso,Brunese Luca,Santone Antonella
Abstract
AbstractThe coronavirus is caused by the infection of the SARS-CoV-2 virus: it represents a complex and new condition, considering that until the end of December 2019 this virus was totally unknown to the international scientific community. The clinical management of patients with the coronavirus disease has undergone an evolution over the months, thanks to the increasing knowledge of the virus, symptoms and efficacy of the various therapies. Currently, however, there is no specific therapy for SARS-CoV-2 virus, know also as Coronavirus disease 19, and treatment is based on the symptoms of the patient taking into account the overall clinical picture. Furthermore, the test to identify whether a patient is affected by the virus is generally performed on sputum and the result is generally available within a few hours or days. Researches previously found that the biomedical imaging analysis is able to show signs of pneumonia. For this reason in this paper, with the aim of providing a fully automatic and faster diagnosis, we design and implement a method adopting deep learning for the novel coronavirus disease detection, starting from computed tomography medical images. The proposed approach is aimed to detect whether a computed tomography medical images is related to an healthy patient, to a patient with a pulmonary disease or to a patient affected with Coronavirus disease 19. In case the patient is marked by the proposed method as affected by the Coronavirus disease 19, the areas symptomatic of the Coronavirus disease 19 infection are automatically highlighted in the computed tomography medical images. We perform an experimental analysis to empirically demonstrate the effectiveness of the proposed approach, by considering medical images belonging from different institutions, with an average time for Coronavirus disease 19 detection of approximately 8.9 s and an accuracy equal to 0.95.
Publisher
Springer Science and Business Media LLC
Reference54 articles.
1. Struyf, T. et al. Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19. Cochrane Database Syst. Rev. 5, 5–11 (2022).
2. Brunese, L., Martinelli, F., Mercaldo, F. & Santone, A. Machine learning for coronavirus COVID-19 detection from chest x-rays. Procedia Comput. Sci. 176, 2212–2221 (2020).
3. Jeyanathan, M., Afkhami, S., Smaill, F., Miller, M.S., Lichty, B. D. & Xing, Z. Immunological considerations for COVID-19 vaccine strategies. Nat. Rev. Immunol. 20, 1–18, (2020).
4. Brunese, L., Mercaldo, F., Reginelli, A., & Santone, A. Explainable deep learning for pulmonary disease and coronavirus COVID-19 detection from x-rays. Comput. Methods Programs Biomed. 196, 105608, (2020).
5. Le, T. T. et al. The COVID-19 vaccine development landscape. Nat. Rev. Drug Discov. 19(5), 305–306 (2020).
Cited by
14 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献